HK1058152A1 - Coated medicament forms with controlled active substance release. - Google Patents

Coated medicament forms with controlled active substance release.

Info

Publication number
HK1058152A1
HK1058152A1 HK04101002A HK04101002A HK1058152A1 HK 1058152 A1 HK1058152 A1 HK 1058152A1 HK 04101002 A HK04101002 A HK 04101002A HK 04101002 A HK04101002 A HK 04101002A HK 1058152 A1 HK1058152 A1 HK 1058152A1
Authority
HK
Hong Kong
Prior art keywords
weight
meth
optionally
acrylate copolymers
active substance
Prior art date
Application number
HK04101002A
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Thomas Backert
Eva Lynenskjold
Original Assignee
Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Gmbh filed Critical Roehm Gmbh
Publication of HK1058152A1 publication Critical patent/HK1058152A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
HK04101002A 1998-10-02 2004-02-13 Coated medicament forms with controlled active substance release. HK1058152A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19845358A DE19845358A1 (de) 1998-10-02 1998-10-02 Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
PCT/EP1999/007179 WO2000019984A2 (fr) 1998-10-02 1999-09-28 Formes medicamenteuses enrobees a liberation controlee du principe actif

Publications (1)

Publication Number Publication Date
HK1058152A1 true HK1058152A1 (en) 2004-05-07

Family

ID=7883150

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04101002A HK1058152A1 (en) 1998-10-02 2004-02-13 Coated medicament forms with controlled active substance release.

Country Status (16)

Country Link
US (1) US6878387B1 (fr)
EP (1) EP1117387B1 (fr)
JP (1) JP4615124B2 (fr)
KR (1) KR100657779B1 (fr)
CN (1) CN1182840C (fr)
AT (1) ATE286724T1 (fr)
AU (1) AU6197499A (fr)
BR (1) BR9913104B1 (fr)
CA (1) CA2346062C (fr)
DE (2) DE19845358A1 (fr)
ES (1) ES2234303T3 (fr)
HK (1) HK1058152A1 (fr)
MX (1) MXPA01003392A (fr)
PL (1) PL193899B1 (fr)
SK (1) SK285295B6 (fr)
WO (1) WO2000019984A2 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10220470A1 (de) * 2002-04-30 2003-11-20 Roehm Gmbh ph-sensitives Polymer
US6162466A (en) * 1999-04-15 2000-12-19 Taro Pharmaceutical Industries Ltd. Sustained release formulation of carbamazepine
DE19961334A1 (de) * 1999-12-17 2001-06-21 Roehm Gmbh Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
ATE510547T1 (de) * 2001-03-08 2011-06-15 Univ Pennsylvania Faciale amphiphile polymere als infektionsbekämpfende mittel
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
TWI252111B (en) * 2001-12-14 2006-04-01 Solvay Pharm Gmbh Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
DE10208335A1 (de) * 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
US20050147698A1 (en) * 2002-03-28 2005-07-07 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
MXPA04010956A (es) 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
JP2006521355A (ja) * 2003-03-17 2006-09-21 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア・センター・フオー・テクノロジー・トランスフアー 表面的に両親媒性のポリマー及びオリゴマーならびにそれらの使用
WO2004103372A1 (fr) * 2003-05-20 2004-12-02 Pfizer Products Inc. Compositions pharmaceutiques a base de varenicline
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (fr) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Pastille robuste
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1658034A4 (fr) 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Produit antibiotique, son utilisation et sa formulation
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
DE10353186A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
CN1922133A (zh) * 2004-01-23 2007-02-28 宾夕法尼亚州大学理事会 表面两亲性聚芳基和聚芳基炔基聚合物和低聚物及其用途
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
CA2574990C (fr) * 2004-07-23 2014-08-26 The Trustees Of The University Of Pennsylvania Copolymeres antimicrobiens et leurs utilisations
JP2008531585A (ja) * 2005-02-25 2008-08-14 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 表面が両親媒性のポリマーおよびオリゴマー、それらの組成物そして癌治療方法におけるそれらの使用
BRPI0609505A2 (pt) * 2005-03-29 2010-04-13 Rihm Gmbh forma farmacêutica em multipartìculas compreendendo péletes com uma matriz que influencia o fornecimento de uma substáncia moduladora
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
ATE553754T1 (de) * 2006-08-18 2012-05-15 Evonik Roehm Gmbh Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser
MX2010007579A (es) * 2008-01-10 2010-08-03 Evonik Roehm Gmbh Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.
WO2009086940A1 (fr) 2008-01-10 2009-07-16 Evonik Röhm Gmbh Préparation pharmaceutique ou nutraceutique enrobée à libération de sustance active améliorée dans le côlon
CN105419206B (zh) * 2009-07-30 2017-12-15 赢创罗姆有限公司 包含共聚物、二羧酸和脂肪单羧酸的粉末状或粒状组合物
KR101647869B1 (ko) 2009-07-30 2016-08-11 에보니크 룀 게엠베하 공중합체, 디카르복실산 및 지방 모노카르복실산을 포함하는 분말 또는 과립 조성물
CA3018328A1 (fr) 2014-10-31 2016-04-30 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
CN110105487B (zh) * 2018-03-09 2021-07-30 广州茂丰药业有限公司 含季铵基(甲基)丙烯酸酯共聚物的溶液聚合制备方法
CA3093077A1 (fr) * 2018-03-09 2019-09-12 Evonik Operations Gmbh Melange polymere dote d'une resistance contre l'influence de l'ethanol
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
JPS62114910A (ja) * 1985-11-13 1987-05-26 エラン　コ−ポレ−シヨン　ピ−　エル　シ− 吸収がコントロ−ルされた医薬製剤
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
EP0640341A1 (fr) * 1993-08-27 1995-03-01 Mitsui Toatsu Chemicals, Incorporated Composition pharmaceutique à libération prolongée et procédé de préparation
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
DE19626045C2 (de) * 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
US6159504A (en) * 1999-01-11 2000-12-12 Kitii Corporation, Ltd. Core substance-containing calcium microparticles and methods for producing the same
JP2001139471A (ja) * 2000-11-20 2001-05-22 Kyoto Pharmaceutical Industries Ltd 矯味経口用医薬組成物

Also Published As

Publication number Publication date
CN1182840C (zh) 2005-01-05
BR9913104B1 (pt) 2010-11-30
ATE286724T1 (de) 2005-01-15
BR9913104A (pt) 2001-05-08
CN1446083A (zh) 2003-10-01
KR20010075502A (ko) 2001-08-09
ES2234303T3 (es) 2005-06-16
JP4615124B2 (ja) 2011-01-19
MXPA01003392A (es) 2003-07-21
CA2346062C (fr) 2008-09-16
PL347780A1 (en) 2002-04-22
SK4262001A3 (en) 2002-10-08
DE19845358A1 (de) 2000-04-06
EP1117387A2 (fr) 2001-07-25
PL193899B1 (pl) 2007-03-30
JP2002526401A (ja) 2002-08-20
WO2000019984A2 (fr) 2000-04-13
DE59911452D1 (de) 2005-02-17
CA2346062A1 (fr) 2000-04-13
US6878387B1 (en) 2005-04-12
WO2000019984A3 (fr) 2000-07-20
EP1117387B1 (fr) 2005-01-12
KR100657779B1 (ko) 2006-12-21
AU6197499A (en) 2000-04-26
SK285295B6 (sk) 2006-10-05

Similar Documents

Publication Publication Date Title
PL347780A1 (en) Coated medicament forms with controlled active substance release
IL167334A (en) Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers
IL175561A0 (en) Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances
TR200100196T2 (tr) Oral veya dermal ilaç biçimleri için kaplama ve birleştirme maddeleri
IL195407A0 (en) Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water
IL146068A0 (en) Multilayer pharmaceutical product for release in the colon
EP2158904A3 (fr) Composition pour l'administration transdermique de Fentanyle
ATE239454T1 (de) Orale morphinzubereitung in teilchenform
MXPA04003970A (es) Granulos o polvo para la produccion de agentes de recubrimiento y aglutinantes para formas farmaceuticas.
IL180849A (en) Medicament in a multilayer form
ATE259637T1 (de) Kontrolliert freisetzende pharmazeutische zubereitung mit einem ace-hemmer als wirkstoff
MX2010007578A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa.
MX2021010914A (es) Forma de dosificacion que comprende una matriz polimerica.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180928